Zobrazeno 1 - 10
of 150
pro vyhledávání: '"matthieu carton"'
Autor:
Monika Sparber‐Sauer, Nadège Corradini, Maria Carmen Affinita, Giuseppe Maria Milano, Gaelle Pierron, Matthieu Carton, Franck Tirode, Daniel Pissaloux, Rita Alaggio, Christian Vokuhl, Gianni Bisogno, Pablo Berlanga, Andrea Ferrari, Daniel Orbach
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14346-14359 (2023)
Abstract Background In certain rare undifferentiated small round cell sarcomas new specific molecular CIC‐DUX4/other partner, BCOR‐CCNB3/other partner, YWHAE fusions, or BCOR‐ITD (internal tandem duplication) were identified. These new “CIC f
Externí odkaz:
https://doaj.org/article/dea8e6b5df8a41f89a769d74263b53f3
Autor:
Anne-Laure Genevois, Matthieu Carton, Myriam Jean-Denis, Joanna Cyrta, Nadège Corradini, Pablo Berlanga, Claire Chemin-Airiau, Charles Honore, Sophie El Zein, Anne-Sophie Defachelles, Emmanuelle Bompas, Philippe Anract, Justine Gantzer, Marie Karanian, Angélique Rome, Florence Duffaud, Christine Chevreau, Sarah Watson, Axel Le Cesne, Carmen Llacer, François Le Loarer, Gaëlle Pierron, François Gouin, Anne Gomez-Mascard, Sylvain Causeret, Françoise Ducimetière, Elsa Kalbacher, Maud Toulmonde, Jean-Yves Blay, Daniel Orbach
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100026- (2023)
Background: Leiomyosarcoma (LMS) and liposarcoma (LPS) are ultra-rare sarcomas in pediatric (0–18 years) and young adult (19−30) populations. We aimed to analyze their clinical characteristics at these young ages and to determine whether they sho
Externí odkaz:
https://doaj.org/article/ce7c19a233f041e78e3deea7fa01d9cf
Autor:
Coralie Courtinard, Sophie Gourgou, William Jacot, Matthieu Carton, Olivier Guérin, Laure Vacher, Aurélie Bertaut, Marie-Cécile Le Deley, David Pérol, Patricia Marino, Christelle Levy, Lionel Uwer, Geneviève Perrocheau, Renaud Schiappa, Florence Bachelot, Damien Parent, Mathias Breton, Thierry Petit, Thomas Filleron, Agnès Loeb, Simone Mathoulin-Pélissier, Mathieu Robain, Suzette Delaloge, Carine Bellera
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Overall survival (OS) is the gold standard endpoint to assess treatment efficacy in cancer clinical trials. In metastatic breast cancer (mBC), progression-free survival (PFS) is commonly used as an intermediate endpoint. Evidence
Externí odkaz:
https://doaj.org/article/95e587a2739d4813945eb54f7074bcab
Autor:
Antoine Vasseur, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marie-Ange Mouret-Reynier, Christelle Levy, Jean-Christophe Eymard, Jean-Marc Ferrero, Marianne Leheurteur, Anthony Goncalves, Marie Robert, Thibault De La Motte Rouge, Thomas Bachelot, Thierry Petit, Marc Debled, Thomas Grinda, Isabelle Desmoulins, Laurence Vanlemmens, Vincent Nicolaï, Gaëtane Simon, Luc Cabel
Publikováno v:
Breast, Vol 65, Iss , Pp 136-144 (2022)
Background: Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been poorly studied in patients previously treated by taxanes in the (neo)adjuvant se
Externí odkaz:
https://doaj.org/article/3e5e3d1b6d254f9091fd5376422aa2e4
Autor:
Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, Paul-Henri Cottu, Véronique Diéras, Florence Dalenc, Anthony Goncalves, Marc Debled, Anne Patsouris, Marie-Ange Mouret-Reynier, Laurence Vanlemmens, Marianne Leheurteur, George Emile, Jean-Marc Ferrero, Isabelle Desmoulins, Lionel Uwer, Jean-Christophe Eymard, Bianca Cheaib, Coralie Courtinard, Thomas Bachelot, Michaël Chevrot, Thierry Petit
Publikováno v:
Breast, Vol 63, Iss , Pp 54-60 (2022)
Purpose: Trastuzumab-emtansine (T-DM1), as well as lapatinib plus capecitabine were proven effective in two Phase III studies, following first-line trastuzumab plus a taxane. The introduction of dual HER2 blockade by trastuzumab and pertuzumab as fir
Externí odkaz:
https://doaj.org/article/91f75990af2445a0a8def40ce2143a62
Autor:
Yassine Bouchoucha, Arnault Tauziède‐Espariat, Arnaud Gauthier, Delphine Guillemot, Dorian Bochaton, Julien Vibert, Matthieu Carton, Sarah Watson, Sandrine Grossetête, Chloé Quignot, Daniel Orbach, Nadège Corradini, Gudrun Schleiermacher, Franck Bourdeaut, Marie Simbozel, Christelle Dufour, Véronique Minard‐Colin, Mehdi Brahmi, Franck Tirode, Daniel Pissaloux, Marie Karanian, Marie‐Christine Machet, Julien Masliah‐Planchon, Olivier Delattre, Liesbeth Cardoen, Gaëlle Pierron, François Doz
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 3, Pp 217-232 (2022)
Abstract BCOR‐ITD tumours form an emerging family of aggressive entities with an internal tandem duplication (ITD) in the last exon of the BCOR gene. The family includes cerebral tumours, termed central nervous system BCOR‐ITD (CNS BCOR‐ITD), a
Externí odkaz:
https://doaj.org/article/e02a318f290e402595038192d567159c
Autor:
Sue Cheeseman, Bethany Levick, Will Sopwith, Hayley Fenton, Eun Ji Nam, DongKyu Kim, Subin Lim, Elodie Martin, Jean-Sébastien Frenel, François Bocquet, Paul Kubelac, Patriciu Achimas-Cadariu, Catalin Vlad, Marion Chevrier, Roman Rouzier, Matthieu Carton, Joana Savva-Bordalo, Marta Magalhães, Marina Borges, Andrea Wolf, Sven Becker, Nicolas Niklas, Mariana Guergova-Kuras, Geoff Hall
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMuch drug development and published analysis for epithelial ovarian cancer (EOC) focuses on early-line treatment. Full sequences of treatment from diagnosis to death and the impact of later lines of therapy are rarely studied. We describe
Externí odkaz:
https://doaj.org/article/26bf76eb219844d9bb87a849e19e5890
Autor:
Luc Cabel, Matthieu Carton, Barbara Pistilli, Florence Dalenc, Laurence Vanlemnens, Christelle Levy, William Jacot, Michel Debled, Agnes Loeb, Audrey Hennequin, Thibault De la Motte Rouge, Lilian Laborde, Carine Laurent, E. Chamorey, Damien Parent, Thierry Petit, Marie-Ange Mouret-Reynier, Mario Campone, Geneviève Perrocheau, Claire Labreveux, Thomas Bachelot, Mathieu Robain, Florence Lerebours
Publikováno v:
Breast, Vol 56, Iss , Pp 18-25 (2021)
Purpose: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study
Externí odkaz:
https://doaj.org/article/9d7301cf07844d3c90e440221410f725
Autor:
Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, Véronique D’Hondt, Audrey Mailliez, Anne Patsouris, Marie-Ange Mouret-Reynier, Anthony Goncalves, Jean Marc Ferrero, Thierry Petit, George Emile, Lionel Uwer, Marc Debled, Florence Dalenc, Christelle Jouannaud, Sylvain Ladoire, Marianne Leheurteur, Paul Cottu, Lucie Veron, Alexia Savignoni, Coralie Courtinard, Mathieu Robain, Suzette Delaloge, Elise Deluche
Publikováno v:
Breast, Vol 55, Iss , Pp 16-24 (2021)
Background: High Body mass index (BMI) is a risk factor for breast cancer among postmenopausal women and an adverse prognostic factor in early-stage. Little is known about its impact on clinical outcomes in patients with metastatic breast cancer (MBC
Externí odkaz:
https://doaj.org/article/4ac8fb7b567c42e6b4d485c16e32498d
Autor:
Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, Florence Dalenc, Audrey Mailliez, Christelle Levy, Véronique D’Hondt, Marc Debled, Thomas Vermeulin, Bruno Coudert, Christophe Perrin, Anthony Gonçalves, Lionel Uwer, Jean-Marc Ferrero, Jean-Christophe Eymard, Thierry Petit, Marie-Ange Mouret-Reynier, Anne Patsouris, Tahar Guesmia, Thomas Bachelot, Mathieu Robain, Paul Cottu
Publikováno v:
Breast, Vol 52, Iss , Pp 50-57 (2020)
Background: Young age is a poor prognostic factor in early stage breast cancer (BC) but its value is less established in metastatic BC (MBC). We evaluated the impact of age at MBC diagnosis on overall survival (OS) across three age groups ( 60 years(
Externí odkaz:
https://doaj.org/article/46d0566de3de487cb6c67e0b263964c8